News Center

BB102, a highly selective and potent reversible-covalent FGFR4 inhibitor induces targeted-protein degradation through lysosomal autophagy

Time of issue：

2026-04-21

Author:

Origin:

previous page

none

BB102, a highly selective and potent reversible-covalent FGFR4 inhibitor effective in multiple xenograft tumor models

next page

previous page

none

next page

BB102, a highly selective and potent reversible-covalent FGFR4 inhibitor effective in multiple xenograft tumor models

address：

A1-602, 88 Kechuang 6th Street, BDA, Beijing 100176

phone：

010-58222729

e-mail：

hr@broadenbio.com

 

Copyright ©2019 BroadenBio

SEO

Powered by www.300.cn

business license